TEVA NEUROSCIENCE, INC. v. WATSON PHARMA, INC.
2:10-cv-05078
Overview
Parties
Mediator
Defendant
APOTEX CORP. Operating Company
Represented By
4 Attorneys ListedPODVEY, MEANOR, CATENACCI, HILDNER COCOZIELLO & CHATTMAN, PC
THE LEGAL CENTER, ONE RIVERFRONT PLAZA
Podvey Meanor Catenacci Hildner Cocoziello & Chattman, P.C.
One Riverfront Plaza, Suite 800
PODVEY, MEANOR, CATENACCI, HILDNER, COCOZIELLO & CHATTMAN PC
THE LEGAL CENTER, ONE RIVERFRONT PLAZA
Plaintiff
Counter Claimant
APOTEX INC. Operating Company
Represented By
4 Attorneys ListedPODVEY, MEANOR, CATENACCI, HILDNER COCOZIELLO & CHATTMAN, PC
THE LEGAL CENTER, ONE RIVERFRONT PLAZA
Podvey Meanor Catenacci Hildner Cocoziello & Chattman, P.C.
One Riverfront Plaza, Suite 800
PODVEY, MEANOR, CATENACCI, HILDNER, COCOZIELLO & CHATTMAN PC
THE LEGAL CENTER, ONE RIVERFRONT PLAZA
Counter Defendant
Court & Judges
Court
District Court, D. New Jersey (njd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 7,572,834 B1 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 7,598,420 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 7,619,117 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 74,282,305 P | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7572834
Rasagiline formulations and processes for their preparation
|
Filed: 2006-12-05
Issued: 2009-08-11
|
Expiring Soon (15 days)
Expires: 2026-12-05
|
Patent Enforceability & Injunction Risk Assessment
Narrowing Window — Less than 6 months of enforceable term remains. Courts rarely grant preliminary or permanent injunctions when term expiration is imminent.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
100
Dispositive
59
Granted
9
Denied
3
Pending / Review
58
Motions by Category
Key Dispositive Motions & Rulings